-+ 0.00%
-+ 0.00%
-+ 0.00%

SpineGuard, Omnia Medical win USPTO notice of allowance for sacroiliac fusion DSG patent application

PUBT·07/27/2026 16:04:31
Listen to the news
SpineGuard, Omnia Medical win USPTO notice of allowance for sacroiliac fusion DSG patent application
  • SpineGuard and Omnia Medical secured a notice of allowance from the USPTO for a U.S. patent on DSG use in sacroiliac joint fusion.
  • Patent covers DSG feedback to guide implant positioning, supporting a U.S. sterile kit pairing Omnia implants with SpineGuard’s PsiFGuard tool.
  • Companies expect faster U.S. commercialization, targeting posterior sacroiliac fusion in ambulatory centers or office-based settings.
  • Sacroiliac joint fusion market exceeded USD 800 million in 2021, projected to grow 16%-20% CAGR through 2030.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SpineGuard SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202607271200BIZWIRE_USPR_____20260727_BW007524) on July 27, 2026, and is solely responsible for the information contained therein.